Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 14.07.2026, 20:29:10
319,70 DKK
Kurs
Kurs
-1,45%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
464,60 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 319,70 285 | 319,70 | 285 | 10,853926 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 319,70 325 | 319,70 | 325 | 1,657804 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 319,70 305 | 319,70 | 305 | 4,598061 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 319,70 300 | 319,70 | 300 | 6,162027 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 319,70 175 | 319,70 | 175 | 45,261182 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 290 | 319,70 | 290 | 9,289959 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 319,70 | 319,70 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 319,70 300 | 319,70 | 300 | 6,162027 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 319,70 263 | 319,70 | 263 | 17,735377 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 319,70 175 | 319,70 | 175 | 45,261182 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 319,70 300 | 319,70 | 300 | 6,162027 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 275 | 319,70 | 275 | 13,981858 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 319,70 263 | 319,70 | 263 | 17,735377 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 319,70 275 | 319,70 | 275 | 13,981858 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 319,70 300 | 319,70 | 300 | 6,162027 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 319,70 260 | 319,70 | 260 | 18,673757 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 319,70 400 | 319,70 | 400 | 25,117297 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 319,70 400 | 319,70 | 400 | 25,117297 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 319,70 275 | 319,70 | 275 | 13,981858 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 319,70 275 | 319,70 | 275 | 13,981858 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 319,70 250 | 319,70 | 250 | 21,801689 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 319,70 340 | 319,70 | 340 | 6,349703 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 319,70 400 | 319,70 | 400 | 25,117297 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 319,70 275 | 319,70 | 275 | 13,981858 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 319,70 475 | 319,70 | 475 | 48,576791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 319,70 332 | 319,70 | 332 | 3,847357 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 319,70 390 | 319,70 | 390 | 21,989365 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 319,70 436 | 319,70 | 436 | 36,377854 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 319,70 415 | 319,70 | 415 | 29,809196 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 319,70 270 | 319,70 | 270 | 15,545824 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 319,70 390 | 319,70 | 390 | 21,989365 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 319,70 390 | 319,70 | 390 | 21,989365 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 319,70 415 | 319,70 | 415 | 29,809196 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 319,70 475 | 319,70 | 475 | 48,576791 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 319,70 390 | 319,70 | 390 | 21,989365 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 319,70 400 | 319,70 | 400 | 25,117297 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 319,70 400 | 319,70 | 400 | 25,117297 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 319,70 360 | 319,70 | 360 | 12,605568 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 319,70 475 | 319,70 | 475 | 48,576791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 319,70 475 | 319,70 | 475 | 48,576791 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 319,70 295 | 319,70 | 295 | 7,725993 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 319,70 295 | 319,70 | 295 | 7,725993 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 319,70 350 | 319,70 | 350 | 9,477635 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 319,70 352 | 319,70 | 352 | 10,103222 | GOLDMAN SACHS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M